Hyperactivity and impulsivity in adult attention-deficit/hyperactivity disorder is related to glutamatergic dysfunction in the anterior cingulate cortex

References

• Altabella L, Zoratto F, Adriani W, Canese R. 2014. MR imaging-detectable metabolic alterations in attention deficit/hyperactivity disorder: from preclinical to clinical studies. AJNR Am J Neuroradiol. 35:55–63.
   PubMed Web of Science ®Google Scholar
• Arnsten AF, Rubia K. 2012. Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders. J Am Acad Child Adolesc Psychiatry. 51:356–367.
   PubMed Web of Science ®Google Scholar
• Biederman J, Fried R, Tarko L, Surman C, Spencer T, Pope A, Grossman R, McDermott K, Woodworth KY, Faraone SV. 2014. Memantine in the treatment of executive function deficits in adults with ADHD: a pilot-randomized double-blind controlled clinical trial. J Atten Disord. [Epub ahead of print]. doi:10.1177/1087054714538656.
   Web of Science ®Google Scholar
• Bollmann S, Ghisleni C, Poil SS, Martin E, Ball J, Eich-Höchli D, Edden RA, Klaver P, Michels L, Brandeis D, et al. 2015. Developmental changes in gamma-aminobutyric acid levels in attention-deficit/hyperactivity disorder. Transl Psychiatry. 5:e589.
   PubMed Web of Science ®Google Scholar
• Bush G. 2011. Cingulate, frontal, and parietal cortical dysfunction in attention-deficit/hyperactivity disorder. Biol Psychiatry. 69:1160–1167.
   PubMed Web of Science ®Google Scholar
• Bush G, Luu P, Posner MI. 2000. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci (Regul Ed). 4:215–222.
   PubMed Web of Science ®Google Scholar
• Boy F, Evans CJ, Edden RA, Lawrence AD, Singh KD, Husain M, Sumner P. 2011. Dorsolateral prefrontal γ-aminobutyric acid in men predicts individual differences in rash impulsivity. Biol Psychiatry. 70:866–872.
   PubMed Web of Science ®Google Scholar
• Bozkurt A, Zilles K, Schleicher A, Kamper L, Arigita ES, Uylings HB, Kötter R. 2005. Distributions of transmitter receptors in the macaque cingulate cortex. Neuroimage. 25:219–229.
   PubMed Web of Science ®Google Scholar
• Carrey NJ, MacMaster FP, Fogel J, Sparkes S. 2007. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 17:11–17.
   PubMed Web of Science ®Google Scholar
• Chang Z, Lichtenstein P, D'Onofrio BM, Sjölander A, Larsson H. 2014. Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. JAMA Psychiatry. 71:319–325.
   PubMed Web of Science ®Google Scholar
• Cherkasova MV, Hechtman L. 2009. Neuroimaging in attention-deficit hyperactivity disorder: beyond the frontostriatal circuitry. Can J Psychiatry. 54:651–664.
   PubMed Web of Science ®Google Scholar
• Dalsgaard S, Mortensen PB, Frydenberg M, Thomsen PH. 2013. Long-term criminal outcome of children with attention deficit hyperactivity disorder. Crim Behav Ment Health. 23:86–98.
   PubMedGoogle Scholar
• Dramsdahl M, Ersland L, Plessen KJ, Haavik J, Hugdahl K, Specht K. 2011. Adults with attention-deficit/hyperactivity disorder: a brain magnetic resonance spectroscopy study. Front Psychiatry. 2:65.
   PubMedGoogle Scholar
• Ende G, Cackowski S, Van Eijk J, Sack M, Demirakca T, Kleindienst N, Bohus M, Sobanski E, Krause-Utz A, Schmahl C. 2015. Impulsivity and aggression in female BPD and ADHD patients: association with ACC glutamate and GABA concentrations. Neuropsychopharmacology. 41:410–418.
   PubMed Web of Science ®Google Scholar
• Endres D, Perlov E, Maier S, Feige B, Nickel K, Goll P, Bubl E, Lange T, Glauche V, Ebert D, et al. 2015. Normal neurochemistry in the prefrontal and cerebellar brain of adults with attention-deficit hyperactivity disorder. Front Behav Neurosci. 9:242.
   PubMed Web of Science ®Google Scholar
• Etkin A, Egner T, Kalisch R. 2011. Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn Sci (Regul Ed). 15:85–93.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Mick E. 2006. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 36:159–165.
   PubMed Web of Science ®Google Scholar
• Findling RL, McNamara NK, Stansbrey RJ, Maxhimer R, Periclou A, Mann A, Graham SM. 2007. A pilot evaluation of the safety, tolerability, pharmacokinetics, and effectiveness of memantine in pediatric patients with attention-deficit/hyperactivity disorder combined type. J Child Adolesc Psychopharmacol. 17:19–33.
   PubMed Web of Science ®Google Scholar
• Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E. 2010. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology. 35:591–604.
   PubMed Web of Science ®Google Scholar
• Frodl T, Skokauskas N. 2012. Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatr Scand. 125:114–126.
   PubMed Web of Science ®Google Scholar
• Hammerness P, Biederman J, Petty C, Henin A, Moore CM. 2012. Brain biochemical effects of methylphenidate treatment using proton magnetic spectroscopy in youth with attention-deficit hyperactivity disorder: a controlled pilot study. CNS Neurosci Therapy. 18:34–40.
   PubMed Web of Science ®Google Scholar
• Hancu I. 2009. Optimized glutamate detection at 3T. J Magn Reson Imaging. 30:1155–1162.
   PubMed Web of Science ®Google Scholar
• Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K. 2013. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry. 70:185–198.
   PubMed Web of Science ®Google Scholar
• Horn W. 1983. Achievement measure system (Leistungs-Pruef-System/LPS), 2nd ed. Goettingen: Hogrefe.
   Google Scholar
• Jun C, Choi Y, Lim SM, Bae S, Hong YS, Kim JE, Lyoo IK. 2014. Disturbance of the glutamatergic system in mood disorders. Exp Neurobiol. 23:28–35.
   PubMedGoogle Scholar
• Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, et al. 2006. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 163:716–723.
   PubMed Web of Science ®Google Scholar
• Kooij JJS. 2012. Adult ADHD. Diagnostic assessment and treatment, 3rd ed. Germany: Springer.
   Google Scholar
• Kreis R. 2016. The trouble with quality filtering based on relative Cramér-Rao lower bounds. Magn Reson Med. 75:15–18.
   PubMed Web of Science ®Google Scholar
• Lehrl S. 2005. Mehrfachwahl-Wortschatz-Intelligenztest MWT-B, 5th ed. Balingen, Germany: Spitta.
   Google Scholar
• Liston C, Malter Cohen M, Teslovich T, Levenson D, Casey BJ. 2011. Atypical prefrontal connectivity in attention-deficit/hyperactivity disorder: pathway to disease or pathological end point? Biol Psychiatry. 69:168–177.
   Web of Science ®Google Scholar
• Ludolph AG, Udvardi PT, Schaz U, Henes C, Adolph O, Weigt HU, Fegert JM, Boeckers TM, Fohr KJ. 2010. Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations. Br J Pharmacol. 160:283–291.
   PubMed Web of Science ®Google Scholar
• Maltezos S, Horder J, Coghlan S, Skirrow C, O'Gorman R, Lavender TJ, Mendez MA, Mehta M, Daly E, Xenitidis K, et al. 2014. Glutamate/glutamine and neuronal integrity in adults with ADHD: a proton MRS study. Transl Psychiatry. 4:e373.
   PubMed Web of Science ®Google Scholar
• McCarthy H, Skokauskas N, Frodl T. 2014. Identifying a consistent pattern of neural function in attention deficit hyperactivity disorder: a meta-analysis. Psychol Med. 44:869–880.
   PubMed Web of Science ®Google Scholar
• Miller EM, Pomerleau F, Huettl P, Gerhardt GA, Glaser PE. 2014. Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder. Psychopharmacology. 231:3019–3029.
   PubMed Web of Science ®Google Scholar
• Moussawi K, Riegel A, Nair S, Kalivas PW. 2011. Extracellular glutamate: functional compartments operate in different concentration ranges. Front Syst Neurosci. 5:94.
   PubMedGoogle Scholar
• Mullins PG, Chen H, Caprihan A, Gasparovic C. 2008. Comparative reliability of proton spectroscopy techniques designed to improve detection of J-coupled metabolites. Magn Reson Med. 60:964–969.
   PubMed Web of Science ®Google Scholar
• Ohrmann P, Siegmund A, Suslow T, Spitzberg K, Kersting A, Arolt V, Heindel W, Pfleiderer B. 2005. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res. 73:153–157.
   PubMed Web of Science ®Google Scholar
• O'Neill J, Lai TM, Sheen C, Salgari GC, Ly R, Armstrong C, Chang S, Levitt JG, Salamon N, Alger JR, Feusner JD. 2016. Cingulate and thalamic metabolites in obsessive-compulsive disorder. Psychiatry Res. 254:34–40.
   PubMed Web of Science ®Google Scholar
• Perlov E, Philipsen A, Hesslinger B, Buechert M, Ahrendts J, Feige B, Bubl E, Hennig J, Ebert D, Tebartz van Elst L. 2007. Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder: a magnet resonance spectroscopy study. J Psychiatr Res. 41:934–941.
   PubMed Web of Science ®Google Scholar
• Perlov E, Philipsen A, Matthies S, Drieling T, Maier S, Bubl E, Hesslinger B, Buechert M, Henning J, Ebert D, et al. 2009. Spectroscopic findings in attention-deficit/hyperactivity disorder: review and meta-analysis. World J Biol Psychiatry. 10:355–365.
   PubMed Web of Science ®Google Scholar
• Pittenger C. 2015. Glutamate modulators in the treatment of obsessive-compulsive disorder. Psychiatr Ann. 45:308–315.
   PubMed Web of Science ®Google Scholar
• Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. 2007. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 164:942–948.
   PubMed Web of Science ®Google Scholar
• Provencher SW. 1993. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 30:672–679.
   PubMed Web of Science ®Google Scholar
• Provencher SW. 2001. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 14:260–264.
   PubMed Web of Science ®Google Scholar
• Rajkowska G, Goldman-Rakic PS. 1995. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II Variability in locations of area 9 and 46 and relationship to Talaraich coordinate system. Cerebr Cortex. 45:323–337.
   Web of Science ®Google Scholar
• Rasmussen KG. 2016. Has psychiatry tamed the ketamine tiger? Considerations on its use for depression and anxiety? Prog Neuropsychopharmacol Biol Psychiatry. 64:218–224.
   PubMed Web of Science ®Google Scholar
• Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH, Rossler M. 2002. Wender Utah Rating Scale (WURS-k). Die deutsche Kurzform zur retrospektiven Erfassung des hyperkinetischen Syndroms bei Erwachsenen [Wender Utah Rating Scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults]. Nervenarzt. 73:830–838.
   PubMed Web of Science ®Google Scholar
• Roesler M, Retz W, Retz-Junginger P, Thome J, Supprian T, Nissen T, Stieglitz R-D, Blocher D, Hengesch G, Trott GE. 2004. Instrumente zur Diagnostik der Aufmerksamkeitsdefizit-Hyperaktivitätsstörung (ADHS) im Erwachsenenalter: Selbstbeurteilungsskala (ADHS-SB) und Diagnosecheckliste (ADHS-DC). Nervenarzt. 75:888–895.
   PubMed Web of Science ®Google Scholar
• Rothman DL, De Feyter HM, de Graaf RA, Mason GF, Behar KL. 2011. 13C MRS studies of neuroenergetics and neurotransmitter cycling in humans. NMR Biomed. 24:943–957.
   PubMed Web of Science ®Google Scholar
• Rüsch N, Boeker M, Büchert M, Glauche V, Bohrmann C, Ebert D, Lieb K, Hennig J, Tebartz Van Elst L. 2010. Neurochemical alterations in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder. World J Biol Psychiatry. 11:372–381.
   PubMed Web of Science ®Google Scholar
• Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, Arnold LE. 2012. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Medicine. 10:99. doi:10.1186/1741-7015-10-99.
   PubMed Web of Science ®Google Scholar
• Schweren LJ, de Zeeuw P, Durston S. 2013. MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder. Eur Neuropsychopharmacol. 23:1151–1164.
   PubMed Web of Science ®Google Scholar
• Silveri MM, Sneider JT, Crowley DJ, Covell MJ, Acharya D, Rosso IM, Jensen JE. 2013. Frontal lobe γ-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition. Biol Psychiatry. 74:296–304.
   PubMed Web of Science ®Google Scholar
• Spencer AE, Uchida M, Kenworthy T, Keary CJ, Biederman J. 2014. Glutamatergic dysregulation in pediatric psychiatric disorders: a systematic review of the magnetic resonance spectroscopy literature. J Clin Psychiatry. 75:1226–1241.
   PubMed Web of Science ®Google Scholar
• Spira EG, Fischel JE. 2005. The impact of preschool inattention, hyperactivity, and impulsivity on social and academic development: a review. J Child Psychol Psychiatry. 46:755–773.
   PubMed Web of Science ®Google Scholar
• Surman CB, Hammerness PG, Petty C, Spencer T, Doyle R, Napolean S, Chu N, Yorks D, Biederman J. 2013. A pilot open label prospective study of memantine monotherapy in adults with ADHD. World J Biol Psychiatry. 14:291–298.
   PubMed Web of Science ®Google Scholar
• Wiguna T, Guerrero AP, Wibisono S, Sastroasmoro S. 2014. The Amygdala's neurochemical ratios after 12 weeks administration of 20 mg long-acting methylphenidate in children with attention deficit and hyperactivity disorder: a pilot study using (1)H magnetic resonance spectroscopy. Clin Psychopharmacol Neurosci. 12:137–141.
   PubMed Web of Science ®Google Scholar
• Wijtenburg SA, Wright SN, Korenic SA, Gaston FE, Ndubuizu N, Chiappelli J, McMahon RP, Chen H, Savransky A, Du X. 2016. Altered glutamate and regional cerebral blood flow levels in schizophrenia: a 1H-MRS and pCASL study. Neuropsychopharmacology. [Epub ahead of print]. doi:10.1038/npp.2016.172.
   Web of Science ®Google Scholar
• Wittchen HU, Zaudig M, Fydrich T. 1997. Strukturiertes Klinisches Interview für DSM-IV. Achse I. Göttingen: Hogrefe.
   Google Scholar
• Yang P, Wu MT, Dung SS, Ko CW. 2010. Short-TE proton magnetic resonance spectroscopy investigation in adolescents with attention-deficit hyperactivity disorder. Psychiatry Res. 181:199–203.
   PubMed Web of Science ®Google Scholar